| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Triapine |
| Disease Entry |
ICD 11 |
Status |
REF |
| Nerve injury |
ND56.4
|
Phase 2 |
[2] |
|
|
|
Triapine Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Ribonucleoside-diphosphate reductase M2 (RRM2)
|
TTBWDI0
|
RIR2_HUMAN
|
Modulator
|
[2] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Triapine Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Histone H2AX (H2AX)
|
OT18UX57
|
H2AX_HUMAN
|
Increases Expression
|
[5] |
|
Thioredoxin-dependent peroxide reductase, mitochondrial (PRDX3)
|
OTLB2WEU
|
PRDX3_HUMAN
|
Increases Oxidation
|
[4] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Terameprocol |
| Disease Entry |
ICD 11 |
Status |
REF |
| Solid tumour/cancer |
2A00-2F9Z
|
Phase 2 |
[3] |
|
|
|
Terameprocol Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Transcription factor Sp1 (SP1)
|
TTZEP6S
|
SP1_HUMAN
|
Modulator
|
[3] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|